BD (NYSE:BDX) announced today that EVP and President of Interventional, Rick Byrd, informed the company that he intends to ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 7, 2026 to ...

BD (NYSE:BDX) announced yesterday that it launched the HemoSphere Stream module for blood pressure monitoring.

BD's HemoSphere Stream Module delivers real-time, noninvasive blood pressure monitoring, enhancing patient safety and ...

BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and ...

A growing number of financial advisors have been leaving their broker-dealer (BD) firms to start or join a registered investment advisor (RIA), an annual industry analysis has found. The study noted ...

Ever since COVID hit, supply chain executives have embraced supply chain risk management. Within this discipline, one of the toughest challenges is how to get visibility to problems arising across the ...

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

After racking up a string of acquisitions throughout 2022—including one of the medtech industry’s largest of the year in its $1.5 billion buyout of Parata Systems—BD has yet to make any major ...

BD has settled on a new name for its new company, the independent spinout that will house its billion-dollar diabetes care business. Embecta is set to launch as its own, publicly traded brand in the ...

BD announced Aug. 25 the promotion of two executives to segment presidents. They will also serve on the Franklin Lakes-based medical tech provider’s executive leadership team. Michael “Mike” Garrison ...